Amylyx Pharmaceuticals Inc (AMLX) Insider Trading
- $326,397.50
- $41,925,685.34
- Sept. 30, 2024
- Morningside Venture Investment
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | Insider | 11,442 | $3.20 | Sell | $36,614.40 | |
| Sept. 30, 2024 | CEO | 18,589 | $3.20 | Sell | $59,484.80 | |
| Sept. 12, 2024 | CFO | 40,000 | $2.53 | Buy | $101,200.00 | |
| Sept. 3, 2024 | Director | 100,000 | $2.20 | Buy | $220,000.00 | |
| May 15, 2024 | Insider | 10,455 | $1.88 | Sell | $19,655.40 | |
| May 14, 2024 | Director | 2,750 | $1.89 | Buy | $5,197.50 | |
| March 5, 2024 | Insider | 1,540 | $18.73 | Sell | $28,844.20 | |
| March 5, 2024 | CEO | 4,135 | $18.73 | Sell | $77,448.55 | |
| March 5, 2024 | CFO | 1,792 | $18.73 | Sell | $33,564.16 | |
| Feb. 23, 2024 | Insider | 2,838 | $18.76 | Sell | $53,240.88 | |
| Jan. 9, 2024 | CEO | 5,841 | $16.33 | Sell | $95,383.53 | |
| Jan. 9, 2024 | CFO | 2,716 | $16.33 | Sell | $44,352.28 | |
| Jan. 9, 2024 | Insider | 2,812 | $16.33 | Sell | $45,919.96 | |
| May 16, 2023 | CFO | 32,500 | $26.94 | Sell | $875,550.00 | |
| May 15, 2023 | Insider | 11,965 | $29.03 | Sell | $347,343.95 | |
| April 17, 2023 | Insider | 49,579 | $30.54 | Sell | $1,514,142.66 | |
| March 29, 2023 | Major Shareholder | 29,048 | $30.45 | Sell | $884,511.60 | |
| March 27, 2023 | Major Shareholder | 60,964 | $30.50 | Sell | $1,859,402.00 | |
| March 21, 2023 | Major Shareholder | 63,448 | $31.91 | Sell | $2,024,625.68 | |
| March 16, 2023 | CEO | 100,000 | $31.86 | Sell | $3,186,000.00 | |
| March 16, 2023 | Insider | 54,627 | $31.87 | Sell | $1,740,962.49 | |
| March 16, 2023 | Director | 35,000 | $31.89 | Sell | $1,116,150.00 | |
| March 16, 2023 | CFO | 32,500 | $31.89 | Sell | $1,036,425.00 | |
| March 16, 2023 | Major Shareholder | 9,122 | $32.55 | Sell | $296,921.10 | |
| March 14, 2023 | Major Shareholder | 70,714 | $34.54 | Sell | $2,442,461.56 | |
| March 2, 2023 | Major Shareholder | 50,000 | $33.75 | Sell | $1,687,500.00 | |
| Feb. 24, 2023 | Insider | 3,586 | $34.49 | Sell | $123,681.14 | |
| Feb. 22, 2023 | Major Shareholder | 50,000 | $34.73 | Sell | $1,736,500.00 | |
| Sept. 8, 2022 | Major Shareholder | 700,000 | $29.37 | Sell | $20,559,000.00 |
Insiders are both buying and selling Amylyx Pharmaceuticals Inc stock.
The insider traders at Amylyx Pharmaceuticals Inc are: Morningside Venture Investment, James M Frates, Patrick D Yeramian, Gina Mazzariello, Justin B Klee, George M Milne Jr, Global Investors Lp Viking, Joshua B Cohen, Daphne Quimi, and Camille L Bedrosian
The most active insider trader at Amylyx Pharmaceuticals Inc is Morningside Venture Investment with 7 trades.
Global Investors Lp Viking has sold the most Amylyx Pharmaceuticals Inc stock with a total value of $41,118,000.00.
George M Milne Jr has bought the most Amylyx Pharmaceuticals Inc stock with a total value of $440,000.00.
The most recent insider trade for Amylyx Pharmaceuticals Inc was on Sept. 30, 2024.
The single biggest insider buy for Amylyx Pharmaceuticals Inc was from George M Milne Jr with a total value of $220,000.00 on Sept. 3, 2024.
The single biggest insider sell for Amylyx Pharmaceuticals Inc was from Global Investors Lp Viking with a total value of $20,559,000.00 on Sept. 8, 2022.